# Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-of-recombinant-activated-factor-vii-in-randomized-clinical-trials/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marcel Levi,Jerrold H. Levy,Henning Friis Andersen,David Truloff |
| Citations | 678 |
| DOI | 10.1056/nejmoa1006221 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1006221?articleTools=true |
| OpenAlex ID | https://openalex.org/W2355654874 |
| PMID | 21047223 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Jerrold H. Levy](https://scholariq.org/researchers/jerrold-h-levy/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)

## Paper topics

- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Blood properties and coagulation](https://scholariq.org/topics/blood-properties-and-coagulation/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.